Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
de Guerrero-García J J, Castañeda-Moreno V A, Torres-Carrillo N, Muñoz-Valle J F, Bitzer-Quintero O K, Ponce-Regalado M D, Mireles-Ramírez M A, Valle Y, Ortuño-Sahagún D
Neuroimmunomodulation. 2015 Nov 25. Epub 2015 Nov 25. PMID: 26599431.Abstract